Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development expenses	$ 27,762,784	$ 29,431,027
General and administrative expenses	15,282,450	12,241,394
Total operating expenses	43,045,234	41,672,421
Loss from operations	(43,045,234)	(41,672,421)
Interest income (expense), net
Interest income	2,902,939	935,180
Interest expense	(4,205,922)	(1,316,519)
Interest income (expense), net	(1,302,983)	(381,339)
Loss before income taxes	(44,348,217)	(42,053,760)
Benefit from income taxes	1,406,019	1,198,905
Net loss	(42,942,198)	(40,854,855)
Comprehensive loss	$ (42,942,198)	$ (40,854,855)
Per share information:
Net loss per share, basic (in dollars per share)	$ (1.39)	$ (1.43)
Net loss per share, diluted (in dollars per share)	$ (1.39)	$ (1.43)
Weighted average common shares outstanding, basic (in shares)	30,952,060	28,599,221
Weighted average common shares outstanding, diluted (in shares)	30,952,060	28,599,221